SEARCH

Current Edition

Upcoming Events

Advertisement

Volume 1 Issue 1

Data-driven Decision-making and Real-world Evidence: Current and Emerging Trends

The likelihood of a high-performing drug launch is approximately one in three, meaning that two-thirds of drug launches fall short of expectations. Capturing the full …

Continue Reading →
New-Immunotherapies-Need-New-Models
Volume 1 Issue 1

New Immunotherapies Need New Models to Reflect New Modalities

Immunotherapy is currently one of the hottest areas in the pharma industry, and development of new targets continues apace. Already, several novel therapeutics have recently …

Continue Reading →
Cognitive-Pharmacovigilance
Volume 1 Issue 1

Cognitive Pharmacovigilance: Business Perspective

Among the major functions of a life science company’s pharmacovigilance (PV) department, case management is one of the most resource-intensive processes, involving considerable manual activities. …

Continue Reading →
Volume 1 Issue 1

Transmucosal Drug Delivery to the Brain via the Nose

A recent paper has shown that macromolecules can pass rapidly from the nose into the brain along olfactory nerves, and into the brain and brain …

Continue Reading →
Inhalation
Volume 1 Issue 1

Inhalation Advances

Respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) remain the third leading cause of death globally and are growing in prevalence throughout the …

Continue Reading →
Zen-and-the-Art-of-Repurposing-Drugs
Volume 1 Issue 1

Zen and the Art of Repurposing Drugs

Once considered a DNA co-purifying annoyance, histone proteins have proven to be an essential component of our genomic makeup. Post-translational modification (PTM) to these proteins …

Continue Reading →
Technology-and-Business-Trends-in-Gene-and-Cell-Therapies
Volume 1 Issue 1

Technology and Business Trends in Gene and Cell Therapies

Investigational Drifts and Technology Synergy Driving Major Opportunities Gene and cell therapies gained industry interest about two decades ago. Since then, a number of therapies …

Continue Reading →
Structural-Analysis-of-Biosimilars
Volume 1 Issue 1

Structural Analysis of Biosimilars

The burgeoning field of biosimilars provides opportunities for biopharma and biotech companies to bring lower-cost products to the marketplace more rapidly than is possible for novel …

Continue Reading →
Pushing-New-Boundaries
Volume 1 Issue 1

Pushing New Boundaries: Technology and Advanced Analytics in Late-phase Research

Technology and advanced analytics in clinical research is an extremely broad topic and its development is accelerating. Within the clinical research environment, late-phase research (Phases …

Continue Reading →
Causes-of-Improved-Patient-Retention-Rates-in-Phase-IIIa-Trials
Volume 1 Issue 1

Causes of Improved Patient Retention Rates in Phase IIIa Trials

Phase IIIa trials represent the final stage in determining whether a drug or medical device can make it to market. These trials normally operate at …

Continue Reading →
Medical-Devices-Regulation
Volume 1 Issue 1

Medical Devices Regulation: The New Rules

The European Parliament adopted proposals for two new EU Regulations on medical devices on 5 April 2017 – one for medical devices and the other …

Continue Reading →
When-to-Paten
Volume 1 Issue 1

When to Patent?

This is always a very difficult question to answer. There are reasons to file an application as early as possible and there are competing reasons …

Continue Reading →
Automated-Biopharmaceutical-Characterisation
Volume 1 Issue 1

Automated Biopharmaceutical Characterisation: From Early Development to Quality Control (QC)

The biophysical characterisation of biopharmaceuticals is critical to the development of a well-controlled large-scale production process. Moreover, as patents expire, the number of biosimilar candidates …

Continue Reading →
The-Rising-Tide-of-Functional-Data-from-Study.
Volume 1 Issue 1

The Rising Tide of Functional Data from Study of the Human and Other Genomes, Aiding in Drug Discovery

Genome editing is not a ‘new’ technology. Genome editing has been around for somewhere between 25 to 30 years. This technology, while forming the foundation …

Continue Reading →
When-the-Pursuit-of-Gold-Standard-Analytics
Volume 1 Issue 1

When the Pursuit of Gold Standard Analytics Reveals Something Greater

Analytics is the discovery, interpretation, and communication of meaningful patterns and knowledge in recorded data. In the life sciences, analytics are crucial for understanding the …

Continue Reading →
How-Making-Screening-is-Easy
Volume 1 Issue 1

How Making Screening is Easy Thanks to SPRimaging – A Label-free Molecular Interaction Analysis Technology

HORIBA Scientific’s unique Surface Plasmon Resonance imaging (SPRi) instrument enables a large number of different label-free molecular interactions to be monitored simultaneously and in parallel …

Continue Reading →
Securing-the-Pharmaceutical-Supply-Chain
Volume 1 Issue 1

Securing the Pharmaceutical Supply Chain: The Blockchain Revolution

The pharmaceutical supply chain is in a state of disruption. Drugs intended to help, heal, and save are being compromised every day – and the …

Continue Reading →